Hemoglobin A1c Test Systems in Canada vs the US: Which Class Applies?

Graduated plastic specimen container with a screw cap on a dark background

Quick facts

  • A hemoglobin A1c test system measures the percentage concentration of hemoglobin A1c in blood, as an aid in the diagnosis of diabetes mellitus and in identifying patients at risk of developing it.
  • In the United States it is a named entry. 21 CFR 862.1373, Hemoglobin A1c test system, is Class II (special controls), with product code PDJ read from the openFDA classification database.
  • Canada keeps no named entry, and the route is different in kind: an in vitro diagnostic device is classified under Part 2 of Schedule 1, not under the Part 1 rules that govern instruments such as analysers and centrifuges.
  • Part 2 Rule 3 places an IVDD intended for patient management in Class II, unless it is for the management of a life-threatening disease or an erroneous result would lead to an imminent life-threatening decision, in which case it is Class III.
  • Part 2 Rule 4 places an IVDD used in diagnosis that is not covered by Rule 3 in Class II, with six listed lifts to Class III that turn on the claim, not on the analyte.
  • Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-16.

A hemoglobin A1c test system measures the percentage concentration of glycated hemoglobin in blood. It is one of the few laboratory tests that is asked for both by name and by number, which makes the class question concrete for a laboratory manager: the United States classes the system by named entry, and Canada classes it as an in vitro diagnostic device under a part of Schedule 1 that many buyers never open. This article sets out both routes and the record a bench keeps, with the graduated 90 mL leak-proof specimen cup that carries the sample to the analyser.

What is a hemoglobin A1c test system?

It is a quantitative test system for hemoglobin A1c - the fraction of hemoglobin that has become glycated - reported as a percentage concentration. The US identification text states the intended use in two halves: measurement of hemoglobin A1c is used as an aid in the diagnosis of diabetes mellitus, and as an aid in the identification of patients at risk for developing diabetes mellitus.

The two halves matter for the Canadian route, because the rules in Part 2 separate diagnosis from patient management. A system whose stated use is to help diagnose answers one rule; a system whose stated use is to help manage patients already treated answers another. The same instrument can be sold both ways, and the claim on the label is what decides which rule the regulator applies.

Graduated plastic specimen container with a screw cap on a dark background

What class is it in the United States?

It is a named entry at 21 CFR 862.1373, titled Hemoglobin A1c test system. The identification reads: "A hemoglobin A1c test system is a device used to measure the percentage concentration of hemoglobin A1c in blood. Measurement of hemoglobin A1c is used as an aid in the diagnosis of diabetes mellitus and as an aid in the identification of patients at risk for developing diabetes mellitus." The regulation sets Class II (special controls).

The openFDA device classification API returns a single product code against the section: PDJ, Class II. Special controls mean the route to market carries requirements beyond general controls, and the regulation itself sets some of them out, starting with an initial requirement on the device that a manufacturer has to meet.

Item Detail
US regulation 21 CFR 862.1373 - Hemoglobin A1c test system
US class Class II (special controls)
Product code PDJ
Stated intended use Aid in the diagnosis of diabetes mellitus; aid in identifying patients at risk
Control regime General controls plus the listed special controls
Read on eCFR identification text and openFDA classification, both read 2026-10-16

How does Canada classify it?

Canada keeps no named entry, and the applicable text is not Part 1 of Schedule 1. An in vitro diagnostic device is classified by Part 2 of the same Schedule, and the first question is whether the device detects a transmissible agent. A hemoglobin A1c system does not, so Rules 1 and 2 of Part 2 do not apply to it.

Part 2 Rule 3 is the patient-management rule: "An IVDD that is intended to be used for patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III: (a) it is intended to be used for the management of patients suffering from a life-threatening disease; or (b) there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient."

Part 2 Rule 4 is the diagnostic rule: "An IVDD that is not subject to rules 1 to 3 and that is intended to be used in diagnosis or patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III", after which the text lists screening for or diagnosis of cancer, genetic testing, screening for congenital disorders in the fetus, a risk that an erroneous result would cause death or severe disability, disease staging, and drug or substance monitoring where an erroneous result leads to an imminent life-threatening decision. A hemoglobin A1c system for routine use answers Rule 3 or Rule 4 at Class II; a system whose stated use reaches one of the lifts answers Class III.

Pair of blue nitrile examination gloves laid out flat for a clinic tray

Why do the two answers look the same but come from different texts?

Both countries land on Class II for a routine hemoglobin A1c claim, and it is tempting to read that as the two systems agreeing. They are not agreeing; they are arriving at the same number from different questions. The United States asks whether the device is the device named in 862.1373 and applies the class written in that entry. Canada asks what the device is used for and applies a rule.

That difference shows up the moment the claim changes. A US sponsor who keeps the same intended use keeps the same entry and the same class. A Canadian sponsor whose intended use moves into one of the Rule 3 or Rule 4 lifts moves a class, even though nothing about the hardware has changed. It also shows up in what the regulator asks for: the special controls attached to the US entry and the evidence expected for a Canadian device licence are not the same set of documents, even at the same class.

Item Canada United States
Named entry None; classified under Part 2 of Schedule 1 862.1373 - Hemoglobin A1c test system
Class, routine diagnosis or management claim Class II (Part 2 Rule 3 or Rule 4) Class II
Class, claim reaching a listed lift Class III Class II
Route for a transmissible-agent claim Part 2 Rules 1 and 2, up to Class IV Not applicable to this entry
Governing text Schedule 1, Part 2, Rules 3 and 4 21 CFR 862.1373
Control regime Device licence conditions set for the class General controls plus special controls

What should a laboratory check before ordering?

Four checks. First, confirm the exact intended-use wording the maker uses, because the Canadian class follows the claim and not the analyte. Second, confirm whether the system is placed in a laboratory or at the point of care, because Part 2 has special rules for near-patient devices and for IVDDs used with another IVDD.

Third, confirm the traceability and control material the maker supplies, because a result that cannot be traced to a stated calibrator cannot be compared across instruments. Fourth, confirm the sample container the system requires, since a result is only as good as the specimen that reached the analyser - and the container is a consumable the bench reorders on its own cycle.

That last point is where the supply line and the classification question meet. Laboratories that buy for more than one bench order through the wholesale programme. Clinics that stock for a whole practice can order through the wholesale programme for case pricing and account setup; resellers can become a distributor. The graduated 90 mL leak-proof specimen cup sits in the same catalogue. Consumables for this line are listed under diagnostic laboratories.

How does the class affect what a bench records?

The class sets the licence path and the conditions attached to it. It does not set the bench routine. What the bench records is set by the maker's instructions and by the laboratory's own quality system: the specimen identifier, the collection time, the instrument, the lot of reagents and controls, the result and the operator.

Laboratories working to an accreditation standard keep the same shape of record whichever class the device sits in, and that is deliberate: the record is what shows the result was produced the way the maker intended, and it is what makes two results comparable when they were produced months apart. The class answers who reviews the device before sale; the record answers whether the run can be trusted.

Sources

  1. openFDA device classification API
  2. Medical Devices Regulations, SOR/98-282, full text and Schedule 1
  3. US FDA, medical device databases
  4. US FDA, overview of device regulation
  5. Health Canada, medical devices
  6. Health Canada, establishment licensing
  7. ISO 15189:2022, medical laboratories, requirements for quality and competence
  8. ISO 17511:2020, metrological traceability of values assigned to calibrators
  9. ISO 13485:2016, medical devices quality management
  10. ISO 14971:2019, application of risk management to medical devices
  11. ISO 11137-1:2006, radiation sterilization of health care products
  12. ISO 20776-1:2019, susceptibility testing of infectious agents
  13. Clinical and Laboratory Standards Institute
  14. World Health Organization
  15. US CDC, laboratory quality
  16. Public Health Ontario, infection prevention and control
  17. Standards Council of Canada

Printable record sheet. A bench record sheet for a quantitative assay holds the specimen, the reagent lot, the control result and the operator on one page. Open the printable bench record sheet — and print a fresh sheet per run - no account and no sign-up.

Log generator. Set the laboratory name, the analyser and the assay once, and the sterilization log generator — produces a dated, facility-labelled sheet you can file beside the run records.

Ask a compliance specialist. A classification question usually turns on how the device is used, not only on its name. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.

Related reading

CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.

Frequently Asked Questions

What class is a hemoglobin A1c test system in the United States?

Class II with special controls, under the named entry at 21 CFR 862.1373, product code PDJ.

What class is it in Canada?

An IVDD is classified under Part 2 of Schedule 1. A routine claim lands at Class II under Part 2 Rule 3 or Rule 4; a claim reaching one of the listed lifts is Class III.

Is hemoglobin A1c classified under the Part 1 rules in Canada?

No. Part 1 governs medical devices other than in vitro diagnostic devices. An IVDD is classified under Part 2, which is why the same instrument can be Class II in Canada while an analyser beside it is placed by a different part of the Schedule.

Could a hemoglobin A1c system be Class III in Canada?

Yes, if the intended use falls into a listed lift - for example management of patients suffering from a life-threatening disease, or a risk that an erroneous result leads to an imminent life-threatening decision.

Does a point-of-care version change the Canadian class?

Part 2 has separate rules for near-patient devices and for an IVDD used with another IVDD, so the placement can differ from a laboratory instrument with the same analyte. The claim and the setting both have to be read.

Does the class change the bench record?

No. The class sets the licence path. The record - specimen, reagent lot, control result, instrument and operator - is set by the maker's instructions and the laboratory quality system.

Already working with clinics? Become a regional representative.